VAERS 2550244
SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ779AA
- Staat
- MI
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 04.01.2023
- Impfdatum
- 30.11.2021
- Beginn
- 31.12.2022
- Tage bis Beginn
- 396,0
- Dosis
- 1
- Route/Site
- IM / -
Symptomtext
COVID+ 12/31/2022. Vaccination status - Moderna x2 + Pfizer x1 Discharge Physician: PRIVATE MD, MPH Primary Care Physician: PRIVATE, MD Date of Admission: 12/31/2022 Discharge Date: 1/1/2023 Room Number: 2021/2021-1 BRIEF OVERVIEW: Active Hospital Problems Diagnosis Date Noted POA ? COVID-19 01/01/2023 Yes ? Pulmonary emphysema (HCC) 01/01/2023 Yes ? Chronic systolic heart failure (HCC) 10/26/2022 Yes ? Amiodarone pulmonary toxicity 10/07/2022 Yes ? Hypertension Yes ? Biventricular automatic implantable cardioverter defibrillator in situ 01/15/2014 Yes ? Cardiomyopathy (HCC) DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 80 y.o. male who presents today with shortness of breath. He has a history of dilated cardiomyopathy with an EF of 29%, ICD, chronic systolic heart failure, HTN, CAD, and pulmonary toxicity from amiodarone. In the ER the patient was initially 93% on room air, but oxygen desaturation to 87% occurred with ambulation with prolonged recovery. He was placed on 2 Liters NC. He tested positive for COVID. Labs included BNP 3,540, procalcitonin 0.08, normal WBC of 8.49. CXR showed emphysema. Hospitalist service consulted for admission further evaluation. He was initiated on dexamethasone and was outside window therapeutic benefit for Remdesivir. He was quickly weaned to room air with stable oxygenation. Patient was advised to follow-up outpatient pulmonology and obtain PFTs which are currently scheduled for 1/27 with local Medical Group pulmonology. Patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 1,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Coronary artery disease involving native coronary artery of native heart without angina pectoris Biventricular automatic implantable cardioverter defibrillator in situ Claudication (HCC) Cardiomyopathy (HCC) Hyperlipidemia Hypertension ICD (implantable cardioverter-defibrillator) discharge Paroxysmal ventricular tachycardia Long term current use of antiarrhythmic drug- Amiodarone Amiodarone pulmonary toxicity Acute respiratory failure with hypoxia (HCC) Chronic systolic heart failure (HCC) Elevated serum creatinine
- Andere Medikamente
- Amiodarone HCl 200 mg Oral Daily Aspirin 81 mg Oral Daily Calcium Carbonate Antacid 500 MG 1 tablet Oral Daily, As needed Carvedilol 12.5 mg Oral 2 times daily Losartan Potassium 50 MG Take 50 mg by mouth daily. Nitroglycerin 0.4 mg Subling
- Allergien
- AmiodaroneOther
- Vorherige Impfungen
- -